Abstract
摘要
相似文献
1
QUAD routes out inferior drugs.四方查处劣质药品。
Can Hosp. 1973 May;50(5):58-9.
2
Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.窄治疗窗药物的生物等效性与可替换性。加拿大药物科学学会讨论
J Pharm Pharm Sci. 1998 Jan-Apr;1(1):2-7.
3
[Guidelines for introducing new drugs for medical use in Poland and control of their quality].[波兰医用新药引进及质量控制指南]
Pol Tyg Lek. 1984;39(51-52):1673-4.
4
3. Drug regulations in Switzerland and their application.3. 瑞士的药品法规及其应用。
Bull Parenter Drug Assoc. 1974 Jul-Aug;28(4):167-73.
5
Drug product quality.药品质量
Exp Med Surg. 1971;29(1):135-44.
6
Rx: Canadian drugs.处方：加拿大药品。
N Engl J Med. 2004 Mar 11;350(11):1155.
7
The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?品牌药与仿制药之争：制药行业中是否存在生产质量更高药品的细分领域？
Contemp Pharm Pract. 1982 Spring;5(2):130-5.
8
Assuring total drug quality.确保药品质量全面达标。
J Am Pharm Assoc. 1973 Feb;13(2):96-8.
9
How to pay less for prescription drugs.如何降低处方药费用。
Consum Rep. 1975 Jan;40(1):48-53.
10
[Standards imposed by the pharmacopoeia on drugs].[药典对药品规定的标准]
Pharm Acta Helv. 1972 Nov-Dec;47(11):648-63.
Zotero 插件